Indication

Idiopathic Inflammatory Myopathy (IIM)

1 clinical trial

1 product

Clinical trial

An Exploartory Trial of IMPT-514, An Autologous Anti-CD19/20 CAR T Therapy in Participants With Active, Refractory Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy

Status: Not yet recruiting, Estimated PCD: 2025-05-31

Product